These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9919719)

  • 1. Meso-2,3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers.
    Restek-Samarzija N; Blanusa M; Pizent A; Samarzija M; Turk R; Corović N; Jurasović J
    Arh Hig Rada Toksikol; 1998 Jun; 49(2):137-45. PubMed ID: 9919719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
    Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
    J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure.
    Counter SA; Ortega F; Shannon MW; Buchanan LH
    Int J Occup Environ Health; 2003; 9(2):164-8. PubMed ID: 12848245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of edetate calcium disodium and dimercaptosuccinic acid in the treatment of lead poisoning in adults.
    Sakthithasan K; Lévy P; Poupon J; Garnier R
    Clin Toxicol (Phila); 2018 Nov; 56(11):1143-1149. PubMed ID: 29889577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA).
    Roels HA; Boeckx M; Ceulemans E; Lauwerys RR
    Br J Ind Med; 1991 Apr; 48(4):247-53. PubMed ID: 1851035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of different lead biomarkers in their associations with lead-related symptoms.
    Lee BK; Ahn KD; Lee SS; Lee GS; Kim YB; Schwartz BS
    Int Arch Occup Environ Health; 2000 Jul; 73(5):298-304. PubMed ID: 10963412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.
    Meldrum JB; Ko KW
    Am J Vet Res; 2003 Jun; 64(6):672-6. PubMed ID: 12828250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral treatment of avian lead intoxication with meso-2,3-dimercaptosuccinic acid.
    Hoogesteijn AL; Raphael BL; Calle P; Cook R; Kollias G
    J Zoo Wildl Med; 2003 Mar; 34(1):82-7. PubMed ID: 12723805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a lead mobilization test using the chelating agent dimercaptosuccinic acid.
    Hoet P; Buchet JP; Decerf L; Lavalleye B; Haufroid V; Lison D
    Clin Chem; 2006 Jan; 52(1):88-96. PubMed ID: 16239340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
    Schwartz BS; Lee BK; Stewart W; Sithisarankul P; Strickland PT; Ahn KD; Kelsey K
    Occup Environ Med; 1997 Apr; 54(4):241-6. PubMed ID: 9166129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lead intoxication in a group of workers in Germany].
    Willi RF; Felgenhauer N; Eyer F; Buters JT; Zilker T
    Dtsch Med Wochenschr; 2009 Dec; 134(50):2556-60. PubMed ID: 19998225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man.
    Hansen JP; Døssing M; Paulev PE
    J Occup Med; 1981 Jan; 23(1):39-43. PubMed ID: 6782204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chelated lead in relation to lead in bone and ALAD genotype.
    Gerhardsson L; Börjesson J; Mattsson S; Schütz A; Skerfving S
    Environ Res; 1999 May; 80(4):389-98. PubMed ID: 10330313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.